138 related articles for article (PubMed ID: 16825093)
1. C-reactive protein is a strong predictor of mortality in hemodialysis patients.
Racki S; Zaputović L; Mavrić Z; Vujicić B; Dvornik S
Ren Fail; 2006; 28(5):427-33. PubMed ID: 16825093
[TBL] [Abstract][Full Text] [Related]
2. The prognostic impact of fluctuating levels of C-reactive protein in Brazilian haemodialysis patients: a prospective study.
Nascimento MM; Pecoits-Filho R; Qureshi AR; Hayashi SY; Manfro RC; Pachaly MA; Renner L; Stenvinkel P; Lindholm B; Riella MC
Nephrol Dial Transplant; 2004 Nov; 19(11):2803-9. PubMed ID: 15496560
[TBL] [Abstract][Full Text] [Related]
3. Serum albumin, C-reactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD.
Honda H; Qureshi AR; Heimbürger O; Barany P; Wang K; Pecoits-Filho R; Stenvinkel P; Lindholm B
Am J Kidney Dis; 2006 Jan; 47(1):139-48. PubMed ID: 16377395
[TBL] [Abstract][Full Text] [Related]
4. Comorbidity and acute clinical events as determinants of C-reactive protein variation in hemodialysis patients: implications for patient survival.
Snaedal S; Heimbürger O; Qureshi AR; Danielsson A; Wikström B; Fellström B; Fehrman-Ekholm I; Carrero JJ; Alvestrand A; Stenvinkel P; Bárány P
Am J Kidney Dis; 2009 Jun; 53(6):1024-33. PubMed ID: 19394732
[TBL] [Abstract][Full Text] [Related]
5. The effect of single and repeatedly high concentrations of C-reactive protein on cardiovascular and non-cardiovascular mortality in patients starting with dialysis.
den Elzen WP; van Manen JG; Boeschoten EW; Krediet RT; Dekker FW
Nephrol Dial Transplant; 2006 Jun; 21(6):1588-95. PubMed ID: 16449284
[TBL] [Abstract][Full Text] [Related]
6. Measurement of circulating troponin Ic enhances the prognostic value of C-reactive protein in haemodialysis patients.
Boulier A; Jaussent I; Terrier N; Maurice F; Rivory JP; Chalabi L; Boularan AM; Delcourt C; Dupuy AM; Canaud B; Cristol JP
Nephrol Dial Transplant; 2004 Sep; 19(9):2313-8. PubMed ID: 15252159
[TBL] [Abstract][Full Text] [Related]
7. C- Reactive protein, cardiac troponin T and low albumin are predictors of mortality in hemodialysis patients.
Bagheri N; Taziki O; Falaknazi K
Saudi J Kidney Dis Transpl; 2009 Sep; 20(5):789-93. PubMed ID: 19736474
[TBL] [Abstract][Full Text] [Related]
8. Excellent agreement between C-reactive protein measurement methods in end-stage renal disease patients--no additional power for mortality prediction with high-sensitivity CRP.
Grootendorst DC; de Jager DJ; Brandenburg VM; Boeschoten EW; Krediet RT; Dekker FW;
Nephrol Dial Transplant; 2007 Nov; 22(11):3277-84. PubMed ID: 17623721
[TBL] [Abstract][Full Text] [Related]
9. Serum carboxymethyllysine predicts mortality in hemodialysis patients.
Wagner Z; Molnár M; Molnár GA; Tamaskó M; Laczy B; Wagner L; Csiky B; Heidland A; Nagy J; Wittmann I
Am J Kidney Dis; 2006 Feb; 47(2):294-300. PubMed ID: 16431258
[TBL] [Abstract][Full Text] [Related]
10. Chronic inflammation and mortality in haemodialysis: effect of different renal replacement therapies. Results from the RISCAVID study.
Panichi V; Rizza GM; Paoletti S; Bigazzi R; Aloisi M; Barsotti G; Rindi P; Donati G; Antonelli A; Panicucci E; Tripepi G; Tetta C; Palla R;
Nephrol Dial Transplant; 2008 Jul; 23(7):2337-43. PubMed ID: 18305316
[TBL] [Abstract][Full Text] [Related]
11. Serum beta2-microglobulin level is a significant predictor of mortality in maintenance haemodialysis patients.
Okuno S; Ishimura E; Kohno K; Fujino-Katoh Y; Maeno Y; Yamakawa T; Inaba M; Nishizawa Y
Nephrol Dial Transplant; 2009 Feb; 24(2):571-7. PubMed ID: 18799606
[TBL] [Abstract][Full Text] [Related]
12. Effect of an increase in C-reactive protein level during a hemodialysis session on mortality.
Korevaar JC; van Manen JG; Dekker FW; de Waart DR; Boeschoten EW; Krediet RT;
J Am Soc Nephrol; 2004 Nov; 15(11):2916-22. PubMed ID: 15504945
[TBL] [Abstract][Full Text] [Related]
13. Usefulness of clinical evaluation, troponins, and C-reactive protein in predicting mortality among stable hemodialysis patients.
Kanwar M; Hashem M; Rosman H; Kamalakannan D; Cheema A; Ali A; Gardin J; Maciejko JJ
Am J Cardiol; 2006 Nov; 98(9):1283-7. PubMed ID: 17056347
[TBL] [Abstract][Full Text] [Related]
14. The impact of malnutrition on mortality in patients on maintenance hemodialysis in Serbia.
Stojanovic M; Stojanovic D; Stefanovic V
Artif Organs; 2008 May; 32(5):398-405. PubMed ID: 18471169
[TBL] [Abstract][Full Text] [Related]
15. The effect of n-3 fatty acids on C-reactive protein levels in patients with chronic renal failure.
Madsen T; Schmidt EB; Christensen JH
J Ren Nutr; 2007 Jul; 17(4):258-63. PubMed ID: 17586424
[TBL] [Abstract][Full Text] [Related]
16. Low serum leptin predicts mortality in patients with chronic kidney disease stage 5.
Scholze A; Rattensperger D; Zidek W; Tepel M
Obesity (Silver Spring); 2007 Jun; 15(6):1617-22. PubMed ID: 17558000
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-6 is a stronger predictor of total and cardiovascular mortality than C-reactive protein in haemodialysis patients.
Panichi V; Maggiore U; Taccola D; Migliori M; Rizza GM; Consani C; Bertini A; Sposini S; Perez-Garcia R; Rindi P; Palla R; Tetta C
Nephrol Dial Transplant; 2004 May; 19(5):1154-60. PubMed ID: 14993508
[TBL] [Abstract][Full Text] [Related]
18. C-reactive protein in patients on chronic hemodialysis with different techniques and different membranes.
Panichi V; Rizza GM; Taccola D; Paoletti S; Mantuano E; Migliori M; Frangioni S; Filippi C; Carpi A
Biomed Pharmacother; 2006 Jan; 60(1):14-7. PubMed ID: 16330177
[TBL] [Abstract][Full Text] [Related]
19. Clinical and biochemical implications of low thyroid hormone levels (total and free forms) in euthyroid patients with chronic kidney disease.
Carrero JJ; Qureshi AR; Axelsson J; Yilmaz MI; Rehnmark S; Witt MR; Bárány P; Heimbürger O; Suliman ME; Alvestrand A; Lindholm B; Stenvinkel P
J Intern Med; 2007 Dec; 262(6):690-701. PubMed ID: 17908160
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of the Centers for Disease Control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease.
Sabatine MS; Morrow DA; Jablonski KA; Rice MM; Warnica JW; Domanski MJ; Hsia J; Gersh BJ; Rifai N; Ridker PM; Pfeffer MA; Braunwald E;
Circulation; 2007 Mar; 115(12):1528-36. PubMed ID: 17372173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]